Skip to main content
logo
Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
18.51
+0.02 (0.11%)
Sep 2, 2026, 4:00 PM EDT - Market closed

Relay Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
10.3515.3610.0125.551.383.03
Revenue Growth
23.88%53.44%-60.83%1749.82%-54.41%-96.34%
Gross Profit
-258.5-241.85-305.43-300.84-241.62-166.36
Operating Income
-310.44-300.44-385.67-379.42-310.95-226.11
Net Income
-286.04-276.48-337.71-341.97-290.51-363.87
Earnings Per Share
-1.57-1.61-2.36-2.79-2.59-3.82
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
910.93554.52781.32750.09998.92958.07
Total Debt
30.6632.4648.553.4757.7422.9
Net Cash (Debt)
880.28522.06732.82696.62941.18935.17
Net Cash Growth
41.39%-28.76%5.20%-25.98%0.64%43.07%
Net Cash Per Share
4.833.045.135.688.399.83

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-212.21-235.46-249.11-300.32-229.49-74.41
Capital Expenditures
--0.41-2.02-4.13-9.06-3.47
Free Cash Flow
-212.21-235.87-251.13-304.44-238.55-77.88
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
-2999.37%-1956.61%-3854.04%-1485.25%-22516.44%-7464.74%
Pretax Margin
-2763.64%-1800.58%-3374.72%-1338.66%-21036.13%-12012.94%
Profit Margin
-2763.64%-1800.58%-3374.72%-1338.66%-21036.13%-12012.94%
FCF Margin
-2050.29%-1536.08%-2509.49%-1191.74%-17273.86%-2571.05%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
391.9195.4968.9153.131307.871095.42